Medsafe has expanded access to the psychedelic drug psilocybin, and the sleep hormone melatonin. The change means melatonin will be available for purchase at pharmacies with no prescription, and psilocybin can be prescribed by a highly experienced psychiatrist for patients with treatment-resistant
